R. Rivera

2.8k total citations
116 papers, 1.1k citations indexed

About

R. Rivera is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, R. Rivera has authored 116 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Immunology, 46 papers in Dermatology and 26 papers in Rheumatology. Recurrent topics in R. Rivera's work include Psoriasis: Treatment and Pathogenesis (61 papers), Dermatology and Skin Diseases (23 papers) and Health Systems, Economic Evaluations, Quality of Life (17 papers). R. Rivera is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (61 papers), Dermatology and Skin Diseases (23 papers) and Health Systems, Economic Evaluations, Quality of Life (17 papers). R. Rivera collaborates with scholars based in Spain, France and United Kingdom. R. Rivera's co-authors include E. Daudén, F. Vanaclocha, I. Belinchón, J.M. Carrascosa, P. de la Cueva, G. Carretero, I. García‐Doval, Marta Ferrán, R. Torrado and J.L. López‐Estebaranz and has published in prestigious journals such as Journal of the American Academy of Dermatology, World Journal of Gastroenterology and British Journal of Dermatology.

In The Last Decade

R. Rivera

105 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Rivera Spain 19 756 460 218 211 152 116 1.1k
Kavitha Goyal United States 12 828 1.1× 389 0.8× 204 0.9× 137 0.6× 114 0.8× 22 1.0k
P. de la Cueva Spain 22 904 1.2× 554 1.2× 188 0.9× 220 1.0× 84 0.6× 107 1.2k
R.J.B. Driessen Netherlands 21 760 1.0× 522 1.1× 186 0.9× 194 0.9× 74 0.5× 40 1.0k
J.L. Sánchez‐Carazo Spain 19 765 1.0× 399 0.9× 195 0.9× 176 0.8× 77 0.5× 34 920
David Williams United States 17 849 1.1× 843 1.8× 152 0.7× 102 0.5× 219 1.4× 23 1.3k
Yin You United States 17 1.0k 1.3× 478 1.0× 341 1.6× 123 0.6× 83 0.5× 34 1.2k
X. Bordas Spain 17 594 0.8× 356 0.8× 176 0.8× 132 0.6× 183 1.2× 33 934
Eva Vilarrasa Spain 20 545 0.7× 610 1.3× 121 0.6× 99 0.5× 219 1.4× 50 967
Pierre‐Dominique Ghislain Belgium 17 685 0.9× 625 1.4× 420 1.9× 67 0.3× 215 1.4× 36 1.5k
A.L.A. Kuijpers Netherlands 16 482 0.6× 241 0.5× 119 0.5× 89 0.4× 80 0.5× 23 710

Countries citing papers authored by R. Rivera

Since Specialization
Citations

This map shows the geographic impact of R. Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Rivera more than expected).

Fields of papers citing papers by R. Rivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Rivera. The network helps show where R. Rivera may publish in the future.

Co-authorship network of co-authors of R. Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of R. Rivera. A scholar is included among the top collaborators of R. Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Rivera. R. Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grau‐Pérez, Mercè, Alejandro Molina‐Leyva, Antonio Martorell, et al.. (2025). ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa. Dermatology. 241(5-6). 1–7.
2.
Ruíz‐Genao, Diana, et al.. (2025). [Translated article] AEDV BIOBADADERM Registry: 15 Year-Contribution to Psoriasis Therapy Safety. Actas Dermo-Sifiliográficas. 116(7). T764–T768.
3.
4.
Arroyo‐Andrés, Jorge, et al.. (2025). Neutrophil Extracellular Trap (NET) Markers in Psoriasis: Linking With Disease Severity and Comorbidities. Actas Dermo-Sifiliográficas. 116(10). 1131–1135. 1 indexed citations
5.
Descalzo, M.Á., Mahmoud Zureik, R. Rivera, et al.. (2024). Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study. British Journal of Dermatology. 192(4). 641–652. 1 indexed citations
6.
Zureik, Mahmoud, R. Rivera, Antonio Sahuquillo‐Torralba, et al.. (2023). Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study. BMJ Open. 13(7). e075197–e075197. 3 indexed citations
7.
Belinchón, I., P. de la Cueva, Yolanda Gilaberte, et al.. (2023). Proyecto CUDERMA: Consenso Delphi de los indicadores de calidad para la certificación de las unidades de dermatología de atención en psoriasis. Actas Dermo-Sifiliográficas. 114(10). 865–883. 1 indexed citations
8.
Rivera, R., Fernando Alfageme, Eva Vilarrasa, et al.. (2023). The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study. Actas Dermo-Sifiliográficas. 114(9). 755–762. 3 indexed citations
9.
Sahuquillo‐Torralba, Antonio, Mar Llamas‐Velasco, R. Rivera, et al.. (2023). Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population. Australasian Journal of Dermatology. 64(4). e317–e326. 3 indexed citations
10.
Rivera, R., Pedro Herranz, P. de la Cueva, et al.. (2022). Ustekinumab to guselkumab transitions: A series of 54 patients emulating the navigate trial in real life. Dermatologic Therapy. 35(10). e15757–e15757. 6 indexed citations
11.
Falkenhain‐López, Daniel, et al.. (2022). Eczematous Reactions Induced by Anti-IL17 Agents. Indian Journal of Dermatology. 67(3). 307–308. 2 indexed citations
12.
Alcázar, E. del, Anna López‐Ferrer, Álvaro Martínez‐Doménech, et al.. (2021). Effectiveness and safety of guselkumab for the treatment of psoriasis in real‐world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group. Dermatologic Therapy. 35(2). e15231–e15231. 18 indexed citations
13.
Rivera, R., Eva Vilarrasa, M. Ribera, et al.. (2020). Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study. Journal of Dermatological Treatment. 33(3). 1329–1338. 8 indexed citations
14.
Aparicio, Gloria, R. Rivera, Eva Vilarrasa, et al.. (2018). Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study. Journal of Dermatological Treatment. 30(5). 461–465. 23 indexed citations
15.
Belinchón, I., José Manuel Ramos, G. Carretero, et al.. (2017). Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate‐to‐severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm. Journal of the European Academy of Dermatology and Venereology. 31(10). 1700–1708. 18 indexed citations
16.
Belinchón, I., R. Rivera, Carles Blanch, Marta Comellas, & Luís Lizán. (2016). Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Preference and Adherence. Volume 10. 2357–2367. 75 indexed citations
17.
Rivera, R., et al.. (2012). Rosácea fulminans inducida por corticoides tópicos: Casos clínicos. Revista médica de Chile. 140(5). 637–639. 4 indexed citations
18.
Rivera, R. & Aurora Guerra Tàpia. (2007). Sirve la finasterida en la alopecia de la mujer. 21–24. 2 indexed citations
19.
Borrego, Leopoldo, et al.. (2002). Tricoepitelioma múltiple familiar asociado a cilindroma y espiradenoma. Síndrome de Brooke-Spiegler. Actas Dermo-Sifiliográficas. 93(4). 254–258. 2 indexed citations
20.
Rivera, R., et al.. (1997). Queratodermia difusa progresiva (enfermedad de Greither). Actas Dermo-Sifiliográficas. 88(3). 119–122. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kavitha Goyal Breakdown of academic impact, for papers by P. de la Cueva Breakdown of academic impact, for papers by R.J.B. Driessen Breakdown of academic impact, for papers by J.L. Sánchez‐Carazo Breakdown of academic impact, for papers by David Williams Breakdown of academic impact, for papers by Yin You Breakdown of academic impact, for papers by X. Bordas Breakdown of academic impact, for papers by Eva Vilarrasa Breakdown of academic impact, for papers by Pierre‐Dominique Ghislain Breakdown of academic impact, for papers by A.L.A. Kuijpers
Rankless by CCL
2026